Cite
S-1 as an option for second-line treatment of NSCLC. Is the 'East Side Story' applicable in the West?
MLA
Hayashi, H., and T. Mitsudomi. “S-1 as an Option for Second-Line Treatment of NSCLC. Is the ‘East Side Story’ Applicable in the West?” Annals of Oncology, vol. 28, no. 11, Nov. 2017, pp. 2627–29. EBSCOhost, https://doi.org/10.1093/annonc/mdx519.
APA
Hayashi, H., & Mitsudomi, T. (2017). S-1 as an option for second-line treatment of NSCLC. Is the “East Side Story” applicable in the West? Annals of Oncology, 28(11), 2627–2629. https://doi.org/10.1093/annonc/mdx519
Chicago
Hayashi, H., and T. Mitsudomi. 2017. “S-1 as an Option for Second-Line Treatment of NSCLC. Is the ‘East Side Story’ Applicable in the West?” Annals of Oncology 28 (11): 2627–29. doi:10.1093/annonc/mdx519.